Search
for
Sort by
Research 30 of 1000+
- Prodrugs of butyric acid from bench to bedside: Synthetic design, mechanisms of action, and clinical applications
- Discovery of Orally Available Prodrugs of Itaconate and Derivatives
- RU 58841-myristate–prodrug development for topical treatment of acne and androgenetic alopecia.
- Minoxidil as a Prodrug: Review of Chemical, Pharmacological, and Technological Aspects in Alopecia Therapeutics
- Advances in nucleoside monophosphate prodrugs as anti-HCV agents
- Comparison of Efficacy and Specificity in Cancer‐Targeting Prodrug Conjugates
- Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata
- PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo
- Novel Fish Oil-based Bigel System for Controlled Drug Delivery and its Influence on Immunomodulatory Activity of Imiquimod Against Skin Cancer
- Engineering MMP9-Responsive Antioxidative Micelle-Hydrogel Dressings for Sequential Inflammatory Remodeling and Pro-Angiogenesis in Diabetic Wound Healing
- Drug‐Free Ultrasound‐Responsive Mechanoluminescent Suture Enables On‐Demand Antibacterial Therapy and Enhanced Healing of Infected Wounds
- Use of Minoxidil Sulfate versus Minoxidil Base in Androgenetic Alopecia Treatment: Friend or Foe?
- Polymer conjugated retinoids for controlled transdermal delivery
- Gallic Acid Nanocrystal Hydrogel: A Novel Strategy for Promoting Wound Healing and Inhibiting Scar Formation
- Poria cocos polysaccharides attenuate chronic nonbacterial prostatitis by targeting the gut microbiota: Comparative study of Poria cocos polysaccharides and finasteride in treating chronic prostatitis
- Air pollution and skin diseases: Adverse effects of airborne particulate matter on various skin diseases
- Advance and Challenges in the Treatment of Skin Diseases with the Transdermal Drug Delivery System
- Engineering a 3D wounded skin equivalent to study early inflammatory and regenerative responses in vitro
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- Impact of Ester Promoieties on Transdermal Delivery of Ketorolac
- Role of skin enzymes in metabolism of topical drugs
- Activity of steroid 4 and derivatives 4a–4f as inhibitors of the enzyme 5α-reductase 1
- Bioorthogonal Catalytic Microneedles Based on a Cytotoxic PEI Matrix for Synergistic Melanoma Therapy
- Agent: Minoxidil
- Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems
- Therapeutic strategies for treating hair loss
- Nitroxide pharmaceutical development for age-related degeneration and disease
- WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH
- Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth
- 711 Small molecule wnt pathway inhibitor (SM04755) as a potential topical psoriasis treatment